| P2093 | author name string | Gian Luigi Gigli | |
| | Giovanni Merlino | |
| P2860 | cites work | "Headbanging" and carotid dissection | Q24675334 |
| | Rhythmic movement disorder: polysomnographic study and summary of reported cases | Q28212445 |
| | Near resolution of sleep related rhythmic movement disorder after CPAP for OSA | Q28239474 |
| | Stiff person syndrome | Q28240589 |
| | Rhythmic movement disorder associated with respiratory arousals and improved by CPAP titration in a patient with restless legs syndrome and sleep apnea | Q28241110 |
| | Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease | Q28241323 |
| | Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology | Q28273976 |
| | Sleep related rhythmic movement disorder revisited | Q28288982 |
| | A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome | Q28303147 |
| | Rhythmic movements in idiopathic REM sleep behavior disorder | Q28307012 |
| | "Headbanging" and fatal subdural haemorrhage | Q29301211 |
| | Projections of diencephalic dopamine neurons into the spinal cord in mice | Q30794467 |
| | Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory data analysis. | Q31086243 |
| | Risk factors for sleep bruxism in the general population | Q31828643 |
| | Quinine for nocturnal leg cramps: a meta-analysis including unpublished data | Q32013656 |
| | One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome | Q33156589 |
| | Propriospinal myoclonus at sleep onset | Q33276763 |
| | Leg symptoms in outpatient veterans | Q33559524 |
| | Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch | Q33709637 |
| | Interventions for leg cramps in pregnancy. | Q33906842 |
| | Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome | Q34221538 |
| | Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health | Q34273561 |
| | Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. | Q34307464 |
| | Restless legs syndrome prevalence and impact: REST general population study | Q34426489 |
| | Prevalence of restless legs syndrome and periodic limb movement disorder in the general population | Q34525455 |
| | Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists | Q34604963 |
| | Managing nocturnal leg cramps--calf-stretching exercises and cessation of quinine treatment: a factorial randomised controlled trial | Q34620128 |
| | Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome | Q34721859 |
| | Restless legs syndrome in end-stage renal disease | Q34734642 |
| | Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community | Q34756341 |
| | Large skull defect in a headbanger | Q66976086 |
| | Hypnic Physiological Myoclonias in Man: An EEG-EMG Study in Normals and Neurological Patients | Q67215662 |
| | Folate deficiency and restless-legs syndrome in pregnancy | Q67660222 |
| | A comparison of different treatments for nocturnal bruxism | Q67932219 |
| | Possible relation between restless legs and anaemia in renal dialysis patients | Q68303103 |
| | The effects of hard and soft occlusal splints on nocturnal bruxism | Q68767490 |
| | Spontaneous electrical activity of human muscle | Q70033806 |
| | Dopaminergic effects on tail-flick response in spinal rats | Q70369784 |
| | Treatment of restless legs syndrome with levodopa plus benserazide | Q70471573 |
| | New actigraphic assessment method for periodic leg movements (PLM) | Q70896700 |
| | The effect of propranolol on sleep bruxism: hypothetical considerations based on a case study | Q71790564 |
| | The effect of catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial | Q71960198 |
| | Nocturnal masseter muscle activity and urinary catecholamine levels in bruxers | Q71985972 |
| | Iron status and restless legs syndrome in the elderly | Q72187356 |
| | Recording and scoring leg movements. The Atlas Task Force | Q72380668 |
| | Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions | Q73315060 |
| | Contributing factors to chronic myofascial pain: a case-control study | Q73826408 |
| | Clonazepam treatment of rhythmic movement disorders | Q73958260 |
| | Restless legs syndrome in an Asian population: A study in Singapore | Q73969847 |
| | A randomized double-blind clinical trial of the effect of amitriptyline on nocturnal masseteric motor activity (sleep bruxism) | Q74241678 |
| | Risk factors for diagnostic subgroups of painful temporomandibular disorders (TMD) | Q74409937 |
| | Urinary catecholamine levels and bruxism in children | Q74611174 |
| | A study of head-banging in infants and chilren | Q78806006 |
| | Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study) | Q79390870 |
| | Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis | Q79580768 |
| | Pathological gambling associated with dopamine agonist use in restless legs syndrome | Q79707398 |
| | Pregabalin in restless legs syndrome with and without neuropathic pain | Q80298311 |
| | Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome | Q80413026 |
| | Predictors of impulsivity and reward seeking behavior with dopamine agonists | Q80803959 |
| | Effect of occlusal interference on habitual activity of human masseter | Q81880256 |
| | The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome | Q84819446 |
| | [Jactatio capitis nocturnus: report of a case in an adult] | Q93590350 |
| | Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial | Q46565350 |
| | Case of symptomatic propriospinal myoclonus evolving toward acute "myoclonic status". | Q46643614 |
| | Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy | Q46689307 |
| | Multiple rhythmic movement disorders in a teenage boy with excellent response to clonazepam | Q46728285 |
| | A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure. | Q46765760 |
| | The neurophysiology of the alternating leg muscle activation (ALMA) during sleep: study of one patient before and after treatment with pramipexole | Q46822407 |
| | Association of body rolling, leg rolling, and rhythmic feet movements in a young adult: A video-polysomnographic study performed before and after one night of clonazepam. | Q46823155 |
| | Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study | Q46827321 |
| | Rhythmic movement disorder | Q46883412 |
| | Prevalence of sleep bruxism in a group of Brazilian schoolchildren. | Q46978357 |
| | Self-inflicted ocular injuries in children. | Q47310746 |
| | The validation of a new actigraphy system for the measurement of periodic leg movements in sleep | Q47696228 |
| | The PAM-RL ambulatory device for detection of periodic leg movements: a validation study | Q47734644 |
| | Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study | Q47877689 |
| | Periodic limb movements in children: prevalence in a referred population | Q47986114 |
| | Periodic limb movements are associated with disturbed sleep. Pro. | Q48142761 |
| | Canadian restless legs syndrome twin study. | Q48176133 |
| | Electrophysiologic disturbances during daytime in patients with restless legs syndrome: further evidence of cognitive dysfunction? | Q48313672 |
| | Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome | Q48314034 |
| | Short-term attention and verbal fluency is decreased in restless legs syndrome patients | Q48341031 |
| | Restless legs syndrome in patients with amyotrophic lateral sclerosis. | Q48347020 |
| | Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome | Q48354710 |
| | The prevalence of restless legs syndrome in Taiwanese adults. | Q48360003 |
| | Correlates of PLMs variability over multiple nights and impact upon RLS diagnosis | Q48417925 |
| | Prevalence of restless legs syndrome in a rural community in Japan | Q48420020 |
| | Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation | Q48420213 |
| | Periodic leg movements during sleep and wakefulness in narcolepsy | Q48459072 |
| | Sleep-related faciomandibular myoclonus: A sleep-related movement disorder different from bruxism | Q48461560 |
| | Validation of the Hopkins telephone diagnostic interview for restless legs syndrome | Q48462007 |
| | Periodic limb movements are NOT associated with disturbed sleep. Con. | Q48466222 |
| | Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe | Q48466535 |
| | Effects of pergolide on severe sleep bruxism in a patient experiencing oral implant failure | Q48471465 |
| | Nocturnal blood pressure changes in patients with restless legs syndrome | Q48472355 |
| | Burden of restless legs syndrome on health-related quality of life | Q48478845 |
| | Restless legs syndrome: diagnosis, epidemiology, classification and consequences | Q48479960 |
| | Long-term treatment with pramipexole in restless legs syndrome | Q48484957 |
| | Excessive fragmentary hypnic myoclonus in a patient affected by a mitochondrial encephalomyopathy | Q48485601 |
| | PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution | Q48488015 |
| | Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). | Q48492037 |
| | Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study | Q48495914 |
| | Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome | Q48498173 |
| | Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort | Q48498697 |
| | The effect of 2 sympatholytic medications--propranolol and clonidine--on sleep bruxism: experimental randomized controlled studies | Q48508344 |
| | The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Stud | Q48514293 |
| | Sleep bruxism: clinical aspects and characteristics in patients with and without chronic orofacial pain | Q48515260 |
| | Cognitive deficits associated with restless legs syndrome (RLS). | Q48531696 |
| | Variability of periodic leg movements in various sleep disorders: implications for clinical and pathophysiologic studies. | Q48533598 |
| | Rhythmic movement disorder in sleep persisting into childhood and adulthood | Q48537798 |
| | Electromyography patterns of propriospinal myoclonus can be mimicked voluntarily | Q48548291 |
| | Night-to-night variability in periodic leg movements in patients with restless legs syndrome | Q48554608 |
| | Aggravation of respiratory disturbances by the use of an occlusal splint in apneic patients: a pilot study. | Q42636487 |
| | Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study | Q42919136 |
| | A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome | Q43064280 |
| | A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist | Q43136975 |
| | Multiple forms of rhythmic movements in an adolescent boy with rhythmic movement disorder | Q43281935 |
| | Long-term effects of pergolide in the treatment of restless legs syndrome | Q43619533 |
| | Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism | Q43629202 |
| | Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron | Q43668004 |
| | Pleuropulmonary disease due to pergolide use for restless legs syndrome. | Q43672954 |
| | Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes | Q43734106 |
| | The effect of four-week administration of amitriptyline on sleep bruxism. A double-blind crossover clinical study | Q43884859 |
| | Multiple blood donations associated with iron deficiency in patients with restless legs syndrome | Q44278854 |
| | Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis | Q44383401 |
| | Nocturnal leg cramps in children: incidence and clinical characteristics. | Q44468200 |
| | Leg cramps in the elderly: prevalence, drug and disease associations. | Q44508444 |
| | Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines | Q44883229 |
| | A general population survey of rest cramps | Q45054276 |
| | Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study | Q45076710 |
| | Restless legs syndrome and pregnancy. | Q45081498 |
| | Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome | Q45082323 |
| | Effective cabergoline treatment in idiopathic restless legs syndrome | Q45205173 |
| | Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. | Q45929136 |
| | Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. | Q46010981 |
| | A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance. | Q46145785 |
| | Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial | Q46185329 |
| | Periodic leg movements in Cheyne-Stokes respiration. | Q46222812 |
| | Periodic Limb M[ovements in Sleep in Community-Dwelling Elderly | Q46328835 |
| | PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome | Q46460102 |
| | Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice | Q34858059 |
| | Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey | Q34938065 |
| | Sleep bruxism; an overview of an oromandibular sleep movement disorder. REVIEW ARTICLE. | Q35046847 |
| | Rhythmic movement disorder in children. | Q35075681 |
| | Iron status and neural functioning | Q35110709 |
| | Restless leg syndrome in pregnancy | Q35705120 |
| | An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. | Q35785060 |
| | Association of restless legs syndrome in type 2 diabetes: a case-control study. | Q35995486 |
| | Rhythmic movements during sleep: a physiological and pathological profile. | Q36332473 |
| | Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment | Q36500874 |
| | A prospective longitudinal study of children. Data on psychic health and development up to 8 years of age. | Q36503519 |
| | A review of the acute subjective effects of MDMA/ecstasy | Q36505757 |
| | Time structure analysis of leg movements during sleep in REM sleep behavior disorder | Q36511595 |
| | EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep | Q36598962 |
| | Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome | Q36599083 |
| | Genesis of sleep bruxism: motor and autonomic-cardiac interactions. | Q36741667 |
| | Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study | Q36800596 |
| | State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome | Q36827987 |
| | Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute | Q36838109 |
| | Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people | Q36901785 |
| | Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls | Q37116481 |
| | Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke | Q37176052 |
| | Bruxism physiology and pathology: an overview for clinicians | Q37192598 |
| | Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders | Q37279108 |
| | Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics | Q37288811 |
| | Leg cramps and restless legs syndrome during pregnancy | Q37467436 |
| | Sleep disturbances and sleep apnea in patients on chronic peritoneal dialysis. | Q37532264 |
| | Management of Voltage-Gated Potassium Channel Antibody Disorders | Q37785176 |
| | When gender matters: restless legs syndrome. Report of the "RLS and woman" workshop endorsed by the European RLS Study Group. | Q37954881 |
| | Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial | Q39430099 |
| | Bruxism secondary to chronic antidopaminergic drug exposure. | Q39492277 |
| | Transient RLS during pregnancy is a risk factor for the chronic idiopathic form | Q39808886 |
| | Rise of blood pressure with periodic limb movements in sleep and wakefulness | Q40201052 |
| | Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome | Q40207333 |
| | First night efficacy of pramipexole in restless legs syndrome and periodic leg movements | Q40211659 |
| | Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. | Q40530268 |
| | Nocturnal electromyographic evaluation of myofascial pain dysfunction in patients undergoing occlusal splint therapy | Q40625184 |
| | Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study | Q40960894 |
| | A more efficient biofeedback procedure for the treatment of nocturnal bruxism | Q41461446 |
| | The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial. | Q42612746 |
| | Restless Legs Syndrome in patients after renal transplantation | Q48563773 |
| | Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis | Q48564916 |
| | Do periodic leg movements influence patients' perception of sleep quality? | Q48575587 |
| | Rhythmic teeth grinding induced by temporal lobe seizures. | Q48589724 |
| | Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival | Q48594861 |
| | Excessive fragmentary hypnic myoclonus: clinical and neurophysiological findings | Q48613609 |
| | State dependent excitability changes of spinal flexor reflex in patients with restless legs syndrome secondary to chronic renal failure | Q48614236 |
| | Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure. | Q48615454 |
| | Alternating leg muscle activation during sleep and arousals: A new sleep‐related motor phenomenon? | Q48629780 |
| | Pelvic movements as rhythmic motor manifestation associated with restless legs syndrome | Q48640166 |
| | Long-term course of restless legs syndrome in dialysis patients after kidney transplantation | Q48649254 |
| | Reliability of a questionnaire screening restless legs syndrome in patients on chronic dialysis | Q48655129 |
| | Familial nocturnal facio-mandibular myoclonus mimicking sleep bruxism | Q48669323 |
| | Rhythmic feet movements while falling asleep | Q48676184 |
| | Variability in sleep bruxism activity over time | Q48680233 |
| | Restless legs syndrome: a clinical study of 55 patients | Q48701164 |
| | MRI measurement of brain iron in patients with restless legs syndrome | Q48705778 |
| | Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. | Q48708716 |
| | Persistence of rhythmic movement disorder beyond childhood: a videotape demonstration | Q48708839 |
| | EEG arousals and awakenings in relation with periodic leg movements during sleep | Q48712664 |
| | Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients | Q48715861 |
| | Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality | Q48721262 |
| | Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome | Q48734881 |
| | Actigraphy and leg movements during sleep: a validation study | Q48761462 |
| | A randomized controlled study of pergolide in patients with restless legs syndrome | Q48768599 |
| | Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study | Q48770123 |
| | Periodic leg movements during sleep and sleep disturbances in elders | Q48787640 |
| | Stress, anticipatory stress, and psychologic measures related to sleep bruxism | Q48828537 |
| | A rhythmic movement disorder in REM sleep: a case report. | Q48847832 |
| | Effects of bromocriptine on periodic limb movements in human narcolepsy | Q48859786 |
| | Periodic limb movements and sleep apnoea | Q48873140 |
| | Frequent occurrence of myoclonus while awake and at rest, body rocking and marching in place in a subpopulation of patients with restless legs syndrome | Q48957931 |
| | Fragmentary pathological myoclonus in NREM sleep | Q49082135 |
| | Kinin generation in the gingival inflammatory response to topically applied bacterial lipopolysaccharides | Q50203912 |
| | Stereotyped behavior in developmentally delayed or autistic populations. Rhythmic or nonrhythmic? | Q50301829 |
| | Adult headbanging: sleep studies and treatment | Q50303159 |
| | Cataracts following chronic headbanging. Report of two cases | Q50312588 |
| | Are periodic leg movements associated with clinical sleep disturbance? | Q51021007 |
| | Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. | Q51533840 |
| | Restless legs syndrome is a common feature of adult celiac disease. | Q53174383 |
| | Prevalence of restless legs syndrome in a Japanese elderly population. | Q53196646 |
| | Restless legs syndrome in hemodialysis patients: association with calcium antagonists. A preliminary report. | Q53233027 |
| | Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. | Q53242298 |
| | Risk factors for restless legs syndrome in dialysis patients. | Q53270434 |
| | "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. | Q53279359 |
| | Clinical and biochemical findings in uremic patients with and without restless legs syndrome. | Q53356123 |
| | Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. | Q55066951 |
| | Augmentation of restless legs syndrome with long-term tramadol treatment | Q56995821 |
| | Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community | Q57534945 |
| | Restless legs syndrome in end-stage renal disease | Q62969952 |
| P433 | issue | 3 | |
| P304 | page(s) | 491-513 | |
| P577 | publication date | 2011-12-28 | |
| P1433 | published in | Neurological Sciences | Q15763262 |
| P1476 | title | Sleep-related movement disorders | |
| P478 | volume | 33 | |